益盛药业: 半年报监事会决议公告

Core Points - The company held its ninth supervisory board's second meeting on August 22, 2025, where all three attending supervisors approved the 2025 semi-annual report [1][2] - The supervisory board confirmed that the procedures for preparing and reviewing the semi-annual report complied with relevant laws and regulations, ensuring the report accurately reflects the company's actual situation without any false records or misleading statements [1][2] Summary by Sections - Meeting Details - The meeting was convened and conducted in accordance with the Company Law and relevant regulations, with all three supervisors present [1] - Approval of Semi-Annual Report - The supervisory board unanimously approved the 2025 semi-annual report with a vote of 3 in favor, 0 against, and 0 abstentions [1] - Report Verification - The supervisory board verified that the report's preparation and review processes met legal and regulatory standards, confirming its authenticity and completeness [1]